CD33 and rheumatoid arthritis: Two previous studies have reported on the resistance to spontaneous death of PBM of arthritic patients; the first examined PB CD33+CD3- cells from JIA patients in low-serum medium [20], while the second examined RA PBM in the presence of a control IgG antibody and low serum [19].